<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[RSS Feed]]></title><description><![CDATA[RSS Feed]]></description><link>http://direct.ecency.com</link><image><url>http://direct.ecency.com/logo512.png</url><title>RSS Feed</title><link>http://direct.ecency.com</link></image><generator>RSS for Node</generator><lastBuildDate>Fri, 24 Apr 2026 04:34:20 GMT</lastBuildDate><atom:link href="http://direct.ecency.com/created/biomarin/rss.xml" rel="self" type="application/rss+xml"/><item><title><![CDATA[BioMarin Pharmaceutical CEO: Treating Hemophilia | Mad Money | CNBC]]></title><description><![CDATA[Jim Cramer takes a key look inside the biotech sector with BioMarin CEO Jean-Jacques Bienaimé. What does the pharmaceutical player have in store? Hear all about its prospects in this exclusive interview.]]></description><link>http://direct.ecency.com/biomarin/@steemit-stats/biomarin-pharmaceutical-ceo-treating-hemophilia-or-mad-money-or-cnbc</link><guid isPermaLink="true">http://direct.ecency.com/biomarin/@steemit-stats/biomarin-pharmaceutical-ceo-treating-hemophilia-or-mad-money-or-cnbc</guid><category><![CDATA[biomarin]]></category><dc:creator><![CDATA[steemit-stats]]></dc:creator><pubDate>Sat, 12 May 2018 22:34:15 GMT</pubDate><enclosure url="https://images.ecency.com/p/S5Eokt4BcQdk7EHeT1aYjzebg2hC7hkthT45dwsnNPhcbGMHvyQQkyd9AKqfopdhgpzMhzE?format=match&amp;mode=fit" length="0" type="false"/></item></channel></rss>